Task: Answer the multiple choice question.
Question: Which drug exhibits a -7.806% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCC(=O)N1CCN(CCN=CC2=C(O)CC(c3ccc(OC)cc3)CC2=O)CC1
b: CCC1CCC2(CC1)NC(=O)N(CC(=O)c1c(C)[nH]c3ccccc13)C2=O
Answer: b. CCC1CCC2(CC1)NC(=O)N(CC(=O)c1c(C)[nH]c3ccccc13)C2=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1CCC2(CC1)NC(=O)N(CC(=O)c1c(C)[nH]c3ccccc13)C2=O
CCC1CCC2(CC1)NC(=O)N(CC(=O)c1c(C)[nH]c3ccccc13)C2=O
8-ethyl-3-[2-(2-methyl-1H-indol-3-yl)-2-oxoethyl]-1,3-diazaspiro[4.5]decane-2,4-dione